WS #13302
AstraZeneca in talks to acquire BMS in ~$400B deal, creating world's 4th largest drugmaker; AZN shares drop 7% on deal risk.
AstraZeneca-BMS merger talks
AstraZeneca in talks to acquire BMS in ~$400B deal, creating world's 4th largest drugmaker; AZN shares drop 7% on deal risk.